| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Takeda Pharmaceutical Co Ltd (TAK) has 1 insider with recent SEC Form 4 filings, including 2 buys and 20 sells. TAK is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 7.00M | $131.39M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 13, 2021 | Takeda Pharmaceutical Co Ltd | 10% Owner | Sell | 11,876 | $35.44 | $420,891.99 | -0.4% | |
| May 7, 2021 | Takeda Pharmaceutical Co Ltd | 10% Owner | Sell | 1,011 | $35.03 | $35,415.33 | - | |
| May 6, 2021 | Takeda Pharmaceutical Co Ltd | 10% Owner | Sell | 7,138 | $35.14 | $250,803.06 | -0.3% | |
| May 4, 2021 | Takeda Pharmaceutical Co Ltd | 10% Owner | Sell | 33,992 | $37.00 | $1,257,848.68 | -0.5% | |
| Jun 30, 2020 | Shire Human Genetic Therapies, Inc. | 10% Owner | Sell | 6,824,992 | $20.68 | $141,140,834.56 | -100% | |
| Jun 3, 2020 | Shire Human Genetic Therapies, Inc. | 10% Owner | Sell | 40,086 | $19.75 | $791,698.50 | -0.6% | |
| Jun 2, 2020 | Shire Human Genetic Therapies, Inc. | 10% Owner | Sell | 213,867 | $19.81 | $4,237,024.07 | -0.8% | |
| Oct 8, 2019 | Takeda Pharmaceutical Co Ltd | 10% Owner | Buy | 2,000,000 | $2.50 | $5,000,000.00 | +53.3% | |
| Mar 19, 2018 | Takeda Pharmaceuticals International AG | 10% Owner | Sell | 7,420,625 | $18.67 | $138,543,068.75 | -100% | |
| Mar 19, 2018 | Takeda Pharmaceuticals International AG | 10% Owner | Buy | 7,420,625 | $18.67 | $138,543,068.75 | New |